CNS Pharmaceuticals Statistics
Total Valuation
CNSP has a market cap or net worth of $2.17 million. The enterprise value is $1.92 million.
| Market Cap | 2.17M |
| Enterprise Value | 1.92M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CNSP has 10.63 million shares outstanding. The number of shares has increased by 176.66% in one year.
| Shares Outstanding | 10.63M |
| Shares Change (YoY) | +176.66% |
| Shares Change (QoQ) | -9.81% |
| Owned by Insiders (%) | 9.53% |
| Owned by Institutions (%) | 3.15% |
| Float | 8.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.26
| Current Ratio | 0.26 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,364.54 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -421.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$6.28M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.54% in the last 52 weeks. The beta is 1.09, so CNSP's price volatility has been similar to the market average.
| Beta (1Y) | 1.09 |
| 52-Week Price Change | -88.54% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 1.22 |
| Relative Strength Index (RSI) | 30.22 |
| Average Volume (30 Days) | 425,572 |
Short Selling Information
The latest short interest is 23,077, so 0.22% of the outstanding shares have been sold short.
| Short Interest | 23,077 |
| Short Previous Month | 49,984 |
| Short % of Shares Out | 0.22% |
| Short % of Float | 0.26% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.87M |
| Pretax Income | -18.85M |
| Net Income | -18.85M |
| EBITDA | -18.83M |
| EBIT | -18.84M |
| Earnings Per Share (EPS) | -$5.00 |
Balance Sheet
The company has $548,721 in cash and $300,806 in debt, giving a net cash position of $247,915 or $0.02 per share.
| Cash & Cash Equivalents | 548,721 |
| Total Debt | 300,806 |
| Net Cash | 247,915 |
| Net Cash Per Share | $0.02 |
| Equity / Book Value | -4.43M |
| Book Value Per Share | -0.42 |
| Working Capital | -4.54M |
Cash Flow
In the last 12 months, operating cash flow was -$14.14 million and capital expenditures -$3,901, giving a free cash flow of -$14.14 million.
| Operating Cash Flow | -14.14M |
| Capital Expenditures | -3,901 |
| Free Cash Flow | -14.14M |
| FCF Per Share | -$3.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -176.66% |
| Shareholder Yield | -176.66% |
| Earnings Yield | -868.91% |
| FCF Yield | -651.94% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 29, 2022. It was a reverse split with a ratio of 1:30.
| Last Split Date | Nov 29, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |